Кодекс долголетия. Что заставляет нас стареть, зачем это нужно и как «обмануть» эволюцию: пошаговое руководство

123 M. Crous-Bou et al., “Mediterranean diet and telomere length in Nurses’ Health Study: population based cohort study.” BMJ (Clinical Research Ed.) 349 (January 2014): g6674.

124 P. Sjogren et al., “Stand up for health – avoiding sedentary behaviour might lengthen your telomeres: secondary outcomes from a physical activity RCT in older people.” British Journal of Sports Medicine 48, no. 19 (September 2014): 1407–9.

125 D. Ornish et al., “Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.” Lancet Oncology 14, no. 11 (October 2013): 1112–20.

126 C. W. Leung et al., “Soda and cell aging: associations between sugar-sweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys.” American Journal of Public Health 104, no. 12 (December 2014): 2425–31.

127 H. Holstege et al., “Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis.” Genome Research 24, no. 5 (April 2014): 733–42.

128 G. Bjelakovic et al., “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.” JAMA 297, no. 8 (February 2007): 842–57.

129 H. Macpherson et al., “Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials.” American Journal of Clinical Nutrition 97, no. 2 (March 2013): 437–44.

130 H. D. Sesso et al., “Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial.” JAMA 308, no. 17 (November 2012): 1751–60.

131 D. H. Baker, “Cupric oxide should not be used as a copper supplement for either animals or humans.” Journal of Nutrition

129, no. 12 (December 1999): 2278–79.

132 G. S. Omenn, “Chemoprevention of lung cancer: the rise and demise of betacarotene.” Annual Review of Public Health 19 (January 1998): 73–99.

133 B. K. Dunn et al., “A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).” Nutrition and Cancer 62, no. 7 (January 2010): 896–918.

134 L. C. Clark et al., “Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.” JAMA 276, no. 24 (December 1996): 1957–63.

135 A. Vogiatzoglou et al., “Vitamin B₁₂ status and rate of brain volume loss in community-dwelling elderly.”

Neurology 71, no. 11 (September 2008): 826–32.

136 G. Douaud et al., “Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment.” Proceedings of the National Academy of Sciences of the United States of America 110, no. 23 (June 2013): 9523–28.

137 N. L. van der Zwaluw et al., “Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.” Neurology 83, no. 23 (December 2014): 2158–66.

138 J. G. Walker et al., “Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms – the Beyond Ageing Project: a randomized controlled trial.” American Journal of Clinical Nutrition 95, no. 1 (January 2012): 194–203.

139 A. D. Smith et al., “Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.” PloS One

5, no. 9 (January 2010): e12244.

140 “Three of the B vitamins: folate, vitamin B₆ and vitamin B₁₂.” Harvard School of Public Health, The Nutrition Source, 2012.

141 W. C. Willett, Eat, Drink, and Be Healthy (New York: Free Press, 2005).

142 Y. Song et al., “Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.” Diabetic Medicine: A Journal of the British Diabetic Association 23, no. 10 (October 2006): 1050–56.

143 F. Guerrero-Romero et al., “Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.” Diabetes and Metabolism 30, no. 3 (June 2004): 253–58.

144 F. C. Mooren et al., “Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial.” Diabetes, Obesity and Metabolism 13, no. 3 (March 2011): 281–84.